CXCL9 and cancer: In contrast, FMRP‐KO cancer cells could recruit CCR5+ and CXCR4+ CD8 T cells to indirectly kill cancer cells by promoting M1 macrophages to secrete proinflammatory chemokines CCL5, CXCL9, and CXCL10.